Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Biotechnology

Bio-Techne Corp develops, manufactures and sells biotechnology products and clinical diagnostic controls. The Company specializes in proteins, cytokines, growth factors, immunoassays and small molecules.
Website: bio-techne.com



Growth: Pretty weak revenue growth rate 2.4%, there is slowdown compared to average historical growth rates 5.2%. The revenue growth dynamics is moderately stable Site traffic for the last 3 months showed a change of +11.1%

Profitability: LTM EBITDA margin is positive, +29.2%. In the last quarter the company beat the estimated EPS, 0.0%. The company was ahead of estimated EPS in 40% of quarters (showing a gain of -$0.06 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.5%. Free cash flow yield 2.4% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 44.9% higher than minimum and 24.4% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.1x by EV / Sales multiple , the company can be 65.4% overvalued

Key Financials (Download financials)

Ticker: TECH
Share price, USD:  (0.0%)67.63
year average price 57.15  


year start price 72.81 2025-02-07

max close price 72.81 2025-02-07

min close price 46.66 2025-05-21

current price 67.63 2026-02-07
Common stocks: 155 839 000

Dividend Yield:  0.5%
FCF Yield LTM: 2.4%
EV / LTM EBITDA: 31.0x
EV / EBITDA annualized: 34.2x
Last revenue growth (y/y):  +8.4%
Last growth of EBITDA (y/y):  +19.7%
Historical revenue growth:  +5.2%
Historical growth of EBITDA:  +0.8%
EV / Sales: 9.1x
Margin (EBITDA LTM / Revenue): 29.2%
Fundamental value created in LTM:
Market Cap ($m): 10 539
Net Debt ($m): 282
EV (Enterprise Value): 10 821
Price to Book: 5.4x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-02-04seekingalpha.com

Bio-Techne Corporation (TECH) Q2 2026 Earnings Call Transcript

2026-02-04zacks.com

Techne (TECH) Beats Q2 Earnings and Revenue Estimates

2026-02-04reuters.com

Biotech firm Bio-Techne beats quarterly estimates on strength in key unit

2026-02-04prnewswire.com

Bio-Techne Releases Second Quarter Fiscal 2026 Results

2026-02-02prnewswire.com

Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative

2026-01-28prnewswire.com

Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers

2026-01-13seekingalpha.com

Bio-Techne Corporation (TECH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2025-12-16globenewswire.com

CMB.TECH INVESTS IN CHINESE AMMONIA SUPPLY

2025-12-09prnewswire.com

Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis

2025-12-02seekingalpha.com

Bio-Techne Corporation (TECH) Presents at Evercore 8th Annual Healthcare Conference Transcript
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q2
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-06-30
symbol TECH TECH TECH TECH TECH TECH TECH TECH TECH TECH TECH TECH TECH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023
fillingDate 2025-11-05 2024-11-05 2024-05-06 2024-02-07 2023-11-07 2023-05-08 2023-02-07 2022-11-07
acceptedDate 2025-11-05 16:31:36 2025-08-22 06:31:16 2024-11-05 16:31:30 2024-08-22 16:30:35 2024-05-06 16:30:44 2024-02-07 16:31:56 2023-11-07 16:35:57 2023-08-23 16:30:51 2023-05-08 16:30:53 2023-02-07 16:30:38 2022-11-07 16:31:06 2022-08-24 16:31:27 2021-08-25 16:46:35
calendarYear 2026 2025 2024 2024 2024 2023 2023 2023
period Q1 FY Q1 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY
revenue 287M 1 220M 289M 1 159M 303M 273M 277M 1 137M 294M 272M 270M 1 106M 931M
costOfRevenue 96M 429M 106M 389M 98M 96M 92M 367M 92M 88M 90M 349M 298M
grossProfit 190M 790M 183M 770M 205M 177M 185M 770M 202M 183M 180M 756M 633M
grossProfitRatio 0.664 0.632 0.676 0.648 0.669 0.687 0.675 0.666
researchAndDevelopmentExpenses 24M 99M 24M 97M 26M 23M 24M 92M 23M 22M 24M 87M 71M
generalAndAdministrativeExpenses 0 415M 0 393M 0 0 0 352M 0 0 0 339M 290M
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 115M 415M 119M 393M 108M 116M 105M 352M 99M 93M 99M 339M 290M
otherExpenses 0 173M 0 73M -874 000 810 000 -6M 26M -15 000 -1M 0 34M 35M
operatingExpenses 139M 688M 143M 563M 133M 139M 129M 471M 122M 115M 123M 460M 396M
costAndExpenses 236M 1 117M 249M 952M 231M 235M 221M 838M 214M 204M 213M 809M 694M
interestIncome 971 000 4M 926 000 3M 712 000 816 000 890 000 3M 974 000 968 000 433 000 794 000 473 000
interestExpense 5M 9M 2M 16M 4M 4M 5M 11M 15 000 2M 4M 11M 14M
depreciationAndAmortization 24M 110M 28M 112M 27M 28M 29M 107M 27M 27M 27M 101M 88M
ebitda 78M 217M 74M 313M 99M 66M 84M 457M 107M 95M 83M 414M 250M
ebitdaratio 0.271 0.255 0.327 0.24 0.305 0.364 0.348 0.308
operatingIncome 51M 102M 40M 207M 72M 38M 56M 299M 80M 68M 56M 297M 237M
operatingIncomeRatio 0.177 0.138 0.237 0.139 0.202 0.273 0.25 0.209
totalOtherIncomeExpensesNet -3M -4M 184 000 -21M -11M -1M -6M 40M -15 000 -1M 47M 5M -89M
incomeBeforeTax 48M 98M 40M 186M 61M 33M 50M 339M 80M 66M 104M 301M 148M
incomeBeforeTaxRatio 0.167 0.139 0.201 0.122 0.179 0.273 0.245 0.385
incomeTaxExpense 10M 25M 7M 18M 12M 6M -1M 53M 10M 16M 14M 38M 9M
netIncome 38M 73M 34M 168M 49M 27M 51M 285M 70M 50M 90M 272M 140M
netIncomeRatio 0.133 0.116 0.162 0.101 0.184 0.239 0.184 0.332
eps 0.25 0.47 0.21 1.07 0.31 0.17 0.32 1.81 0.45 0.32 0.57 1.73 0.91
epsdiluted 0.24 0.21 0.31 0.17 0.31 0.43 0.31 0.55
weightedAverageShsOut 155M 158M 159M 158M 157M 158M 158M 157M 157M 157M 157M 157M 155M
weightedAverageShsOutDil 156M 160M 161M 161M 160M 160M 162M 162M 162M 162M 162M 164M 162M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-08-22 2024-08-22 2023-08-23 2022-08-24 2021-08-25
fiscalYear 2025 2024 2023 2022 2021
netInterestIncome -5M -12M -8M -11M -13M
ebit 107M 201M 350M 313M 162M
nonOperatingIncomeExcludingInterest -5M 5M -51M -16M 75M
netIncomeFromContinuingOperations 73M 168M 285M 263M 140M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 73M 168M 285M 272M 140M
epsDiluted 0.46 1.05 1.76 1.66 0.87

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q2
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-06-30
symbol TECH TECH TECH TECH TECH TECH TECH TECH TECH TECH TECH TECH TECH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023
fillingDate 2025-11-05 2024-11-05 2024-05-06 2024-02-07 2023-11-07 2023-05-08 2023-02-07 2022-11-07
acceptedDate 2025-11-05 16:31:36 2025-08-22 06:31:16 2024-11-05 16:31:30 2024-08-22 16:30:35 2024-05-06 16:30:44 2024-02-07 16:31:56 2023-11-07 16:35:57 2023-08-23 16:30:51 2023-05-08 16:30:53 2023-02-07 16:30:38 2022-11-07 16:31:06 2022-08-24 16:31:27 2021-08-25 16:46:35
calendarYear 2026 2025 2024 2024 2024 2023 2023 2023
period Q1 FY Q1 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY
cashAndCashEquivalents 145M 162M 188M 152M 140M 130M 149M 181M 127M 165M 165M 173M 199M
shortTermInvestments 0 0 0 1M 5M 6M 0 24M 30M 32M 38M 74M 32M
cashAndShortTermInvestments 145M 162M 188M 153M 145M 136M 149M 204M 157M 197M 203M 247M 232M
netReceivables 184M 207M 224M 241M 228M 207M 205M 218M 216M 185M 174M 195M 145M
inventory 203M 189M 185M 180M 179M 181M 186M 172M 169M 160M 150M 141M 117M
otherCurrentAssets 77M 50M 52M 43M 58M 40M 52M 27M 28M 23M 25M 23M 17M
totalCurrentAssets 610M 608M 649M 617M 611M 591M 591M 621M 571M 565M 552M 606M 511M
propertyPlantEquipmentNet 311M 319M 343M 342M 341M 335M 334M 325M 322M 308M 294M 289M 282M
goodwill 979M 981M 983M 973M 971M 980M 969M 873M 871M 870M 865M 822M 843M
intangibleAssets 350M 366M 486M 507M 526M 551M 579M 535M 553M 568M 586M 532M 616M
goodwillAndIntangibleAssets 1 329M 1 347M 1 469M 1 480M 1 497M 1 531M 1 548M 1 407M 1 424M 1 437M 1 451M 1 354M 1 459M
longTermInvestments 266M 251M 256M 242M 260M 250M -83M 256M 0 0 0 0 275 000
taxAssets 0 10M 0 0 64M 72M 83M 0 95M 111M 0 0 0
otherNonCurrentAssets 10M 23M 19M 22M -52M -47M 282M 29M 189M -58M 54M 47M 11M
totalNonCurrentAssets 1 917M 1 950M 2 087M 2 086M 2 111M 2 140M 2 164M 2 017M 2 029M 1 798M 1 799M 1 689M 1 752M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 2 526M 2 558M 2 736M 2 704M 2 721M 2 731M 2 755M 2 639M 2 600M 2 363M 2 351M 2 295M 2 263M
accountPayables 30M 25M 32M 38M 29M 32M 79M 26M 81M 69M 30M 34M 29M
shortTermDebt 14M 14M 27M 13M 13M 13M 12M 11M 11M 11M 12M 13M 13M
taxPayables 0 11M 3M 4M 12M 7M 6M 12M 18M 25M 17M 13M 5M
deferredRevenue 30M 33M 27M 28M 30M 28M 25M 23M 25M 22M 22M 23M 19M
otherCurrentLiabilities 70M -12M 54M -11M 78M 63M 12M -10M 24M 27M 73M 1M 4M
totalCurrentLiabilities 145M 176M 142M 159M 150M 135M 128M 129M 141M 128M 138M 176M 152M
longTermDebt 381M 346M 385M 319M 389M 543M 537M 350M 463M 278M 329M 243M 329M
deferredRevenueNonCurrent 2M 0 3M 0 2M 2M 1M 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 11M 6M 50M 56M 64M 72M 83M 89M 95M 111M 113M 99M 93M
otherNonCurrentLiabilities 22M 27M 17M 13M 102M 16M 8M 11M 11M 18M 397M 17M 50M
totalNonCurrentLiabilities 416M 463M 455M 476M 557M 632M 630M 544M 569M 408M 462M 418M 539M
otherLiabilities 0 0 0 0 1 0 0 0 0 0 0 0 0
capitalLeaseObligations 81M 98M 99M 101M 93M 109M 110M 105M 104M 89M 77M 70M 79M
totalLiabilities 560M 639M 597M 635M 707M 767M 758M 672M 710M 536M 600M 594M 692M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 392 000 2M 390 000
retainedEarnings 1 083M 1 066M 1 341M 1 325M 1 298M 1 261M 1 328M 1 309M 1 247M 1 200M 1 163M 1 123M 1 085M
accumulatedOtherComprehensiveIncomeLoss -64M -60M -60M -78M -75M -64M -78M -66M -74M -75M -92M -75M -57M
othertotalStockholdersEquity 946M 856M 790M 764M 747M 715M 701M 680M
totalStockholdersEquity 1 966M 1 919M 2 139M 2 069M 2 014M 1 964M 1 998M 1 967M 1 890M 1 827M 1 751M 1 702M 1 563M
totalEquity 1 966M 1 919M 2 139M 2 069M 2 014M 1 964M 1 998M 1 967M 1 890M 1 827M 1 751M 1 701M 1 571M
totalLiabilitiesAndStockholdersEquity 2 526M 2 736M 2 721M 2 731M 2 755M 2 600M 2 363M 2 351M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 -759 000 8M
totalLiabilitiesAndTotalEquity 2 526M 2 558M 2 736M 2 704M 2 721M 2 731M 2 755M 2 639M 2 600M 2 363M 2 351M 2 295M 2 263M
totalInvestments 266M 251M 256M 243M 265M 6M -83M 280M 30M 32M 38M 74M 32M
totalDebt 394M 444M 399M 420M 495M 556M 550M 455M 474M 289M 342M 326M 421M
netDebt 250M 282M 211M 268M 355M 426M 401M 274M 347M 124M 176M 153M 221M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-08-22 2024-08-22 2023-08-23 2022-08-24 2021-08-25
fiscalYear 2025 2024 2023 2022 2021
accountsReceivables 207M 241M 218M 195M 145M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 0 0
totalPayables 36M 42M 41M 47M 39M
otherPayables 11M 4M 16M 13M 9M
accruedExpenses 91M 75M 52M 80M 67M
capitalLeaseObligationsCurrent 14M 13M 11M 12M 12M
capitalLeaseObligationsNonCurrent 84M 88M 94M 58M 68M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 911M 820M 722M 652M 534M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q2
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-06-30
symbol TECH TECH TECH TECH TECH TECH TECH TECH TECH TECH TECH TECH TECH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023 842 023
fillingDate 2025-11-05 2024-11-05 2024-05-06 2024-02-07 2023-11-07 2023-05-08 2023-02-07 2022-11-07
acceptedDate 2025-11-05 16:31:36 2025-08-22 06:31:16 2024-11-05 16:31:30 2024-08-22 16:30:35 2024-05-06 16:30:44 2024-02-07 16:31:56 2023-11-07 16:35:57 2023-08-23 16:30:51 2023-05-08 16:30:53 2023-02-07 16:30:38 2022-11-07 16:31:06 2022-08-24 16:31:27 2021-08-25 16:46:35
calendarYear 2026 2025 2024 2024 2024 2023 2023 2023
period Q1 FY Q1 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY
netIncome 38M 73M 34M 168M 49M 27M 51M 285M 70M 50M 90M 263M 140M
depreciationAndAmortization 24M 110M 28M 112M 27M 28M 29M 107M 27M 27M 27M 101M 88M
deferredIncomeTax 5M -51M -5M -39M -8M -11M -12M -30M -16M -2M -5M 7M -27M
stockBasedCompensation 12M 41M 10M 38M 8M 13M 10M 39M 10M 17M 14M 42M 49M
changeInWorkingCapital -43M 12M -10M -10M 1M 19M 2M -91M -39M -17M -23M -70M 29M
accountsReceivables 22M 43M 22M -31M -23M 5M 16M -23M 0 0 17M -58M -16M
inventory -14M -18M 188 000 -14M -22 000 -4M 181 000 -30M -10M -8M -11M -32M -7M
accountsPayables -2M -14M -11M 26M 2M 8M -3M -8M 6M -10M -1M 13M 19M
otherWorkingCapital -49M 1M -21M 9M 23M 10M -11M -29M -35M 436 000 -28M 7M 33M
otherNonCashItems -9M 103M 7M 31M 87M 7M -21M -57M -1M -10M -47M -18M 74M
netCashProvidedByOperatingActivities 28M 288M 64M 299M 81M 83M 59M 254M 51M 64M 56M 325M 352M
investmentsInPropertyPlantAndEquipment -5M -31M -9M -63M -16M -15M -14M -38M -12M -6M -10M -45M -44M
acquisitionsNet 0 -15M 0 -170M 0 -3M -164M -83M -131M 0 -83M 0 -226M
purchasesOfInvestments 0 -6M 0 -6M 0 -6M -2M -21M 21M 15M -15M -25M -40M
salesMaturitiesOfInvestments 0 1M 1M 28M -2M 6M 24M 108M -27M 12M 73M 26M 66M
otherInvestingActivites 6M -14M 2M -6M 2M -93M -21M 15M
netCashUsedForInvestingActivites 605 000 -22M -16M -24M -154M -241M -109 000 -20M
debtRepayment -46M -19M -58M -58M -70M 0 -65M -441M
commonStockIssued 0 25M 18M 70M 14M 0 0 0
commonStockRepurchased -24 000 -276M 0 -80M -168 000 -80M -20M -20M 0 0 -20M -161M -43M
dividendsPaid -12M -13M -13M -13M -13M -13M -13M -13M
otherFinancingActivites 14M -5M -168 000 -1M 160M 163M 5M 441M
netCashUsedProvidedByFinancingActivities -44M -12M -52M -81M 72M 151M -72M -32M
effectOfForexChangesOnCash -1M 12M 5M -2M -2M 3M -9M -3M 2M 7M -12M -12M 6M
netChangeInCash -17M 10M 36M -29M 10M -19M -32M 8M -37M -575 000 -7M -27M 52M
cashAtEndOfPeriod 145M 162M 188M 152M 140M 130M 149M 181M 127M 165M 165M 173M 199M
cashAtBeginningOfPeriod 162M 152M 152M 181M 130M 149M 181M 173M 165M 165M 173M 199M 147M
operatingCashFlow 28M 288M 64M 299M 81M 83M 59M 254M 51M 64M 56M 325M 352M
capitalExpenditure -5M -31M -9M -63M -16M -15M -14M -38M -12M -6M -10M -45M -44M
freeCashFlow 22M 257M 55M 236M 65M 68M 46M 216M 39M 58M 47M 280M 308M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-08-22 2024-08-22 2023-08-23 2022-08-24 2021-08-25
fiscalYear 2025 2024 2023 2022 2021
otherInvestingActivities 15M 7M -232M -53M 0
netCashProvidedByInvestingActivities -35M -203M -266M -97M -244M
netDebtIssuance 27M -31M 94M -86M -16M
longTermNetDebtIssuance 27M -31M 94M -86M -272M
shortTermNetDebtIssuance 0 0 0 0 256M
netStockIssuance -276M -80M -20M -161M -43M
netCommonStockIssuance -276M -80M -20M -161M -43M
commonStockIssuance 0 0 0 0 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -50M -50M -50M -50M -50M
commonDividendsPaid -50M -50M -50M -50M -50M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 45M 39M -2M 54M 46M
netCashProvidedByFinancingActivities -254M -122M 23M -243M -63M
incomeTaxesPaid 74M 65M 88M 30M 21M
interestPaid 19M 15M 8M 11M 14M

Earning call transcript

2025 q4
2026-02-04 ET (fiscal 2026 q2)
2025 q3
2025-11-05 ET (fiscal 2026 q1)
2025 q2
2025-08-06 ET (fiscal 2025 q4)
2025 q1
2025-05-07 ET (fiscal 2025 q3)
2024 q4
2025-02-05 ET (fiscal 2025 q2)
2024 q3
2024-10-30 ET (fiscal 2025 q1)
2024 q2
2024-08-07 ET (fiscal 2024 q4)
2024 q1
2024-05-01 ET (fiscal 2024 q3)
2023 q4
2024-02-01 ET (fiscal 2024 q2)
2023 q3
2023-10-31 ET (fiscal 2024 q1)
2023 q2
2023-08-08 ET (fiscal 2023 q4)
2023 q1
2023-05-03 ET (fiscal 2023 q3)
2022 q4
2023-02-02 ET (fiscal 2023 q2)
2022 q3
2022-11-01 ET (fiscal 2023 q1)
2022 q2
2022-08-06 ET (fiscal 2022 q4)
2022 q1
2022-05-04 ET (fiscal 2022 q3)
2021 q4
2022-02-01 ET (fiscal 2022 q2)
2021 q3
2021-11-02 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2026-02-04 21:31 ET
Bio-Techne reported for 2025 q4
SEC form 8
2026-02-04 11:30 ET
Bio-Techne published news for 2025 q4
SEC form 8
2026-02-04 11:30 ET
Bio-Techne published news for 2025 q4
SEC form 8
2026-02-04 11:30 ET
Bio-Techne published news for 2025 q4
SEC form 10
2025-11-05 16:31 ET
Bio-Techne reported for 2025 q3
SEC form 8
2025-11-05 06:31 ET
Bio-Techne published news for 2025 q3
SEC form 8
2025-11-05 06:31 ET
Bio-Techne reported for 2025 q3
SEC form 8
2025-11-05 06:31 ET
Bio-Techne published news for 2025 q3
SEC form 10
2025-08-22 10:31 ET
Bio-Techne reported for 2025 q2
SEC form 8
2025-08-06 10:30 ET
Bio-Techne published news for 2025 q2
SEC form 8
2025-08-06 10:30 ET
Bio-Techne reported for 2025 q2
SEC form 8
2025-08-06 10:30 ET
Bio-Techne published news for 2025 q2
SEC form 10
2025-05-08 20:30 ET
Bio-Techne reported for 2025 q1
SEC form 10
2025-05-08 00:00 ET
Bio-Techne reported for 2025 q1
SEC form 8
2025-05-07 10:30 ET
Bio-Techne published news for 2025 q1
SEC form 8
2025-05-07 10:30 ET
Bio-Techne reported for 2025 q1
SEC form 8
2025-05-07 10:30 ET
Bio-Techne published news for 2025 q1
SEC form 10
2025-02-06 21:30 ET
Bio-Techne reported for 2024 q4
SEC form 10
2025-02-06 00:00 ET
Bio-Techne reported for 2024 q4
SEC form 8
2025-02-05 00:00 ET
Bio-Techne published news for 2024 q4
SEC form 8
2025-02-05 00:00 ET
Bio-Techne reported for 2024 q4
SEC form 8
2025-02-05 00:00 ET
Bio-Techne published news for 2024 q4
SEC form 8
2025-02-05 00:00 ET
Bio-Techne published news for 2024 q4
SEC form 10
2024-11-05 16:31 ET
Bio-Techne reported for 2024 q3
SEC form 8
2024-10-30 06:30 ET
Bio-Techne published news for 2024 q3
SEC form 8
2024-10-30 06:30 ET
Bio-Techne reported for 2024 q3
SEC form 8
2024-10-30 06:30 ET
Bio-Techne published news for 2024 q3
SEC form 10
2024-08-22 00:00 ET
Bio-Techne reported for 2024 q2
SEC form 8
2024-08-07 06:32 ET
Bio-Techne published news for 2024 q2
SEC form 8
2024-08-07 06:32 ET
Bio-Techne reported for 2024 q2
SEC form 8
2024-08-07 06:32 ET
Bio-Techne published news for 2024 q2
SEC form 10
2024-05-06 00:00 ET
Bio-Techne reported for 2024 q1
SEC form 8
2024-05-01 06:30 ET
Bio-Techne published news for 2024 q1
SEC form 8
2024-05-01 06:30 ET
Bio-Techne reported for 2024 q1
SEC form 8
2024-05-01 06:30 ET
Bio-Techne published news for 2024 q1
SEC form 10
2024-02-07 00:00 ET
Bio-Techne reported for 2023 q4
SEC form 8
2024-02-01 00:00 ET
Bio-Techne published news for 2023 q4
SEC form 8
2024-02-01 00:00 ET
Bio-Techne reported for 2023 q4
SEC form 8
2024-02-01 00:00 ET
Bio-Techne published news for 2023 q4
SEC form 10
2023-11-07 00:00 ET
Bio-Techne published news for 2023 q3
SEC form 8
2023-10-31 06:30 ET
Bio-Techne reported for 2023 q3
SEC form 10
2023-08-23 00:00 ET
Bio-Techne published news for 2023 q2
SEC form 6
2023-08-08 06:30 ET
Bio-Techne reported for 2023 q2
SEC form 8
2023-08-08 00:00 ET
Bio-Techne published news for 2023 q2
SEC form 10
2023-05-08 00:00 ET
Bio-Techne reported for 2023 q1
SEC form 8
2023-05-03 00:00 ET
Bio-Techne reported for 2023 q1
SEC form 6
2023-04-03 07:01 ET
Bio-Techne published news for 2023 q1
SEC form 6
2023-03-01 07:30 ET
Bio-Techne published news for 2022 q4
SEC form 10
2023-02-07 16:30 ET
Bio-Techne reported for 2022 q4
SEC form 10
2023-02-07 00:00 ET
Bio-Techne published news for 2022 q4
SEC form 6
2023-02-02 06:31 ET
Bio-Techne published news for 2022 q4
SEC form 8
2023-02-02 00:00 ET
Bio-Techne reported for 2022 q4
SEC form 6
2023-01-31 08:00 ET
Bio-Techne published news for 2022 q4
SEC form 10
2022-11-07 16:31 ET
Bio-Techne reported for 2022 q3
SEC form 10
2022-11-07 00:00 ET
Bio-Techne reported for 2022 q3
SEC form 6
2022-11-01 06:32 ET
Bio-Techne published news for 2022 q3
SEC form 8
2022-11-01 00:00 ET
Bio-Techne reported for 2022 q3
SEC form 6
2022-09-14 07:00 ET
Bio-Techne published news for 2022 q2
SEC form 6
2022-09-07 06:31 ET
Bio-Techne published news for 2022 q2
SEC form 6
2022-09-01 07:00 ET
Bio-Techne published news for 2022 q2
SEC form 10
2022-08-24 16:31 ET
Bio-Techne reported for 2022 q2
SEC form 10
2022-08-24 00:00 ET
Bio-Techne reported for 2022 q2
SEC form 6
2022-08-05 06:31 ET
Bio-Techne published news for 2022 q2
SEC form 6
2022-08-04 06:30 ET
Bio-Techne published news for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Bio-Techne reported for 2022 q2
SEC form 10
2022-05-09 16:30 ET
Bio-Techne reported for 2022 q1
SEC form 10
2022-05-09 00:00 ET
Bio-Techne reported for 2022 q1
SEC form 6
2022-05-04 06:35 ET
Bio-Techne published news for 2022 q1
SEC form 8
2022-05-04 00:00 ET
Bio-Techne reported for 2022 q1
SEC form 6
2022-04-27 16:32 ET
Bio-Techne published news for 2022 q1
SEC form 10
2022-02-07 16:30 ET
Bio-Techne published news for 2021 q4
SEC form 10
2022-02-07 00:00 ET
Bio-Techne published news for 2021 q4
SEC form 6
2022-02-01 06:30 ET
Bio-Techne published news for 2021 q4
SEC form 8
2022-02-01 00:00 ET
Bio-Techne published news for 2021 q4
SEC form 6
2021-12-22 16:30 ET
Bio-Techne published news for 2021 q3
SEC form 10
2021-11-08 16:32 ET
Bio-Techne published news for 2021 q3
SEC form 10
2021-11-08 00:00 ET
Bio-Techne published news for 2021 q3
SEC form 6
2021-11-02 06:30 ET
Bio-Techne published news for 2021 q3
SEC form 8
2021-11-02 00:00 ET
Bio-Techne published news for 2021 q3
SEC form 6
2021-10-29 16:31 ET
Bio-Techne published news for 2021 q3
SEC form 6
2021-09-14 16:05 ET
Bio-Techne published news for 2021 q2
SEC form 10
2021-08-25 16:46 ET
Bio-Techne published news for 2021 q2
SEC form 10
2021-08-25 00:00 ET
Bio-Techne published news for 2021 q2
SEC form 6
2021-08-05 06:32 ET
Bio-Techne published news for 2021 q2
SEC form 8
2021-08-05 00:00 ET
Bio-Techne published news for 2021 q2
SEC form 10
2021-05-07 16:32 ET
Bio-Techne published news for 2021 q1
SEC form 10
2021-05-07 00:00 ET
Bio-Techne published news for 2021 q1
SEC form 6
2021-05-06 06:33 ET
Bio-Techne published news for 2021 q1
SEC form 8
2021-05-06 00:00 ET
Bio-Techne published news for 2021 q1
SEC form 10
2021-02-08 06:31 ET
Bio-Techne published news for 2020 q4
SEC form 6
2021-02-02 06:34 ET
Bio-Techne published news for 2020 q4
SEC form 10
2020-11-09 06:31 ET
Bio-Techne published news for 2020 q3
SEC form 6
2020-11-05 06:32 ET
Bio-Techne published news for 2020 q3
SEC form 6
2020-11-03 16:30 ET
Bio-Techne published news for 2020 q3
SEC form 6
2020-09-15 17:00 ET
Bio-Techne published news for 2020 q2